Gainers
- Cosmos Holdings COSM shares increased by 27.9% to $0.15 during Friday's pre-market session. The market value of their outstanding shares is at $12.3 million.
- Chemomab Therapeutics CMMB stock rose 24.51% to $2.59. The company's market cap stands at $29.6 million. As per the press release, Q3 earnings came out today.
- Doximity DOCS shares moved upwards by 21.34% to $31.95. The company's market cap stands at $6.1 billion. As per the news, the Q2 earnings report came out yesterday.
- SenesTech SNES shares moved upwards by 18.53% to $0.18. The company's market cap stands at $2.1 million.
- Otonomy OTIC shares rose 16.68% to $0.1. The market value of their outstanding shares is at $5.6 million. The company's, Q3 earnings came out yesterday.
- ContraFect CFRX stock moved upwards by 15.91% to $0.16. The market value of their outstanding shares is at $6.2 million.
Losers
- Redhill Biopharma RDHL shares fell 25.6% to $0.46 during Friday's pre-market session. The market value of their outstanding shares is at $29.2 million. As per the news, the Q2 earnings report came out 4 days ago.
- AirSculpt Technologies AIRS stock decreased by 23.26% to $3.63. The company's market cap stands at $201.9 million. As per the news, the Q3 earnings report came out yesterday.
- Nexalin Technology NXL shares fell 13.52% to $1.6. The market value of their outstanding shares is at $11.6 million.
- FIGS FIGS stock decreased by 10.96% to $5.85. The market value of their outstanding shares is at $967.2 million. As per the news, the Q3 earnings report came out yesterday.
- Nutex Health NUTX shares declined by 8.49% to $0.77. The market value of their outstanding shares is at $501.0 million.
- PDS Biotechnology PDSB shares decreased by 7.49% to $5.12. The market value of their outstanding shares is at $145.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in